Screening the in vitro sperm-immobilizing effect of some anticancer drugs

Area of Science:

• Reproductive toxicology
• Pharmacology

Background:

• Anticancer agents can impact reproductive health.
• Understanding the specific mechanisms of sperm toxicity is crucial.

Purpose of the Study:

• To screen seven common anticancer agents for their in vitro sperm-immobilizing effects.
• To identify which agents affect human sperm motility and elucidate their potential mechanism of action.

Main Methods:

• Utilized a transmembrane migration assay to assess sperm motility.
• Exposed human sperm to cyclophosphamide, 5-fluorouracil, cytarabine, mitomycin-C, 6-mercaptopurine, doxorubicin, and vinblastine.
• Included colchicine, a microtubular inhibitor, as a control.

Main Results:

• Doxorubicin and vinblastine significantly inhibited human sperm motility in vitro.
• Cyclophosphamide, 5-fluorouracil, cytarabine, 6-mercaptopurine, and mitomycin-C showed no significant effect on sperm motility.
• Colchicine, a known microtubular inhibitor, did not affect sperm motility.

Conclusions:

• Doxorubicin and vinblastine are potent inhibitors of human sperm motility.
• The lack of effect from colchicine suggests that microtubule disruption is not the primary mechanism.
• The sperm membrane is proposed as the likely site of action for doxorubicin and vinblastine's inhibitory effects on sperm motility.